{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T17:21:52Z","timestamp":1793467312524,"version":"4.5.0"},"reference-count":40,"publisher":"Japanese Society for Lymphoreticular Tissue Research","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCEH","J Clin Exp Hematopathol"],"published-print":{"date-parts":[[2023]]},"DOI":"10.3960\/jslrt.23007","type":"journal-article","created":{"date-parts":[[2023,6,27]],"date-time":"2023-06-27T22:12:46Z","timestamp":1687903966000},"page":"121-131","source":"Crossref","is-referenced-by-count":10,"title":["High-grade B-cell lymphoma with 11q aberrations: A single-center study"],"prefix":"10.3960","volume":"63","author":[{"given":"Shoki","family":"Yamada","sequence":"first","affiliation":[{"name":"Department of Diagnostic Pathology, Fukushima Medical University School of Medicine, Fukushima, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuka","family":"Oka","sequence":"additional","affiliation":[{"name":"Department of Diagnostic Pathology, Fukushima Medical University School of Medicine, Fukushima, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moe","family":"Muramatsu","sequence":"additional","affiliation":[{"name":"Department of Diagnostic Pathology, Fukushima Medical University School of Medicine, Fukushima, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuko","family":"Hashimoto","sequence":"additional","affiliation":[{"name":"Department of Diagnostic Pathology, Fukushima Medical University School of Medicine, Fukushima, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2349","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1 Alaggio R, Amador C, Anagnostopoulos I, et al. The 5th Edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms. Leukemia. 2022; 36: 1720-1748.","DOI":"10.1038\/s41375-022-01620-2"},{"key":"2","unstructured":"2 Swerdlow SHC, Campo E, Jaffe ES, et al. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissue [OP] (Medicine). 4th ed, World Health Organization. 2008."},{"key":"3","doi-asserted-by":"crossref","unstructured":"3 Swerdlow SH, Campo E, Pileri SA et al.<\/i> The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood. 2016; 127: 2375-2390.","DOI":"10.1182\/blood-2016-01-643569"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4 Pienkowska-Grela B, Rymkiewicz G, Grygalewicz B et al.<\/i> Partial trisomy 11, dup(11)(q23q13), as a defect characterizing lymphomas with Burkitt pathomorphology without MYC gene rearrangement. Med Oncol. 2011; 28: 1589-1595.","DOI":"10.1007\/s12032-010-9614-0"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5 Salaverria I, Martin-Guerrero I, Wagener R et al.<\/i> A recurrent 11q aberration pattern characterizes a subset of MYC-negative high-grade B-cell lymphomas resembling Burkitt lymphoma. Blood. 2014; 123: 1187-1198.","DOI":"10.1182\/blood-2013-06-507996"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6 Ferreiro JF, Morscio J, Dierickx D et al.<\/i> Post-transplant molecularly defined Burkitt lymphomas are frequently MYC-negative and characterized by the 11q-gain\/loss pattern. Haematologica. 2015; 100: e275-e279.","DOI":"10.3324\/haematol.2015.124305"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7 Gebauer N, Witte HM, Merz H et al.<\/i> Aggressive B-cell lymphoma cases with 11q aberration patterns indicate a spectrum beyond Burkitt-like lymphoma. Blood Adv. 2021; 5: 5220-5225.","DOI":"10.1182\/bloodadvances.2021004635"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8 Kim JA, Kim HY, Kim SJ, Kim HJ, Kim SH. A case of Burkitt-like lymphoma with 11q aberration with HIV infection in East Asia and literature review. Ann Lab Med. 2021; 41: 593-597.","DOI":"10.3343\/alm.2021.41.6.593"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9 Grygalewicz B, Woroniecka R, Rymkiewicz G et al.<\/i> The 11q-gain\/loss aberration occurs recurrently in MYC-negative Burkitt-like lymphoma with 11q aberration, as well as MYC-positive Burkitt lymphoma and MYC-positive high-grade B-cell lymphoma, NOS. Am J Clin Pathol. 2017; 149: 17-28.","DOI":"10.1093\/ajcp\/aqx139"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10 Gonzalez-Farre B, Ramis-Zaldivar JE, Salmeron-Villalobos J et al.<\/i> Burkitt-like lymphoma with 11q aberration: a germinal center-derived lymphoma genetically unrelated to Burkitt lymphoma. Haematologica. 2019; 104: 1822-1829.","DOI":"10.3324\/haematol.2018.207928"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11 Loeffler-Wirth H, Kreuz M, Hopp L et al.<\/i> A modular transcriptome map of mature B cell lymphomas. Genome Med. 2019; 11: 27.","DOI":"10.1186\/s13073-019-0637-7"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12 Campo E, Jaffe ES, Cook JR et al.<\/i> The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee. Blood. 2022; 140: 1229-1253.","DOI":"10.1182\/blood.2022015851"},{"key":"13","unstructured":"13 Leoncini L, Siebert R, Ferry JA, et al. Burkitt lymphoma. In: WHO Classification of Tumours Editorial Board. Haematolymphoid tumours [Internet; beta version ahead of print]. Lyon (France): International Agency for Research on Cancer; 2022 [cited 2023\/03\/01]. (WHO classification of tumours series, 5th ed.; vol. 11). Available from: https: \/\/tumourclassification.iarc.who.int\/chapters\/63."},{"key":"14","unstructured":"14 Rosenwald A, Leoncini L, Macon WR, et al. Diffuse large B-cell lymphoma \/ high grade B-cell lymphoma with MYC and BCL2 rearrangements. In: WHO Classification of Tumours Editorial Board. Haematolymphoid tumours [Internet; beta version ahead of print]. Lyon (France): International Agency for Research on Cancer; 2022 [cited 2023\/03\/01]. (WHO classification of tumours series, 5th ed.; vol. 11). Available from: https: \/\/tumourclassification.iarc.who.int\/chapters\/63."},{"key":"15","unstructured":"15 Delabie J, Medeiros LJ, Klapper W, et al. Diffuse large B-cell lymphoma, NOS. In: WHO Classification of Tumours Editorial Board. Haematolymphoid tumours [Internet; beta version ahead of print]. Lyon (France): International Agency for Research on Cancer; 2022 [cited 2023\/03\/01]. (WHO classification of tumours series, 5th ed.; vol. 11). Available from: https: \/\/tumourclassification.iarc.who.int\/chapters\/63."},{"key":"16","doi-asserted-by":"crossref","unstructured":"16 Horn H, Kalmbach S, Wagener R et al.<\/i> A diagnostic approach to the identification of Burkitt-like lymphoma with 11q aberration in aggressive B-cell lmphomas. Am J Surg Pathol. 2021; 45: 356-364.","DOI":"10.1097\/PAS.0000000000001613"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17 Yu YT, Takeuchi K, Baba S, Chang KC. Morphologically suspected Burkitt-like lymphoma with 11q aberrations confirmed by fluorescence in situ hybridization. Am J Surg Pathol. 2022; 46: 576-577.","DOI":"10.1097\/PAS.0000000000001805"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18 Nozawa Y, Abe M, Ohno H, Fukuhara S, Wakasa H. Production of two monoclonal antibodies (FB1 and FB21) useful for the identification of human B lymphocytes in formalin-fixed, paraffin-embedded tissues. J Pathol. 1994; 173: 347-354.","DOI":"10.1002\/path.1711730410"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19 Hans CP, Weisenburger DD, Greiner TC et al.<\/i> Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray. Blood. 2004; 103: 275-282.","DOI":"10.1182\/blood-2003-05-1545"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20 Havelange V, Ameye G, Th\u00e9ate I et al.<\/i> The peculiar 11q-gain\/loss aberration reported in a subset of MYC-negative high-grade B-cell lymphomas can also occur in a MYC-rearranged lymphoma. Cancer Genet. 2016; 209: 117-118.","DOI":"10.1016\/j.cancergen.2015.12.005"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21 Au-Yeung RKH, Arias Padilla L, Zimmermann M et al.<\/i> Experience with provisional WHO\u2010entities large B\u2010cell lymphoma with IRF4 \u2010rearrangement and Burkitt\u2010like lymphoma with 11q aberration in paediatric patients of the NHL\u2010BFM group. Br J Haematol. 2020; 190: 753-763.","DOI":"10.1111\/bjh.16578"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22 Kim M, Hwang HS, Yoon DH, Chun SM, Go H. Distinct genetic alterations in Burkitt-like lymphoma with 11q aberration and Burkitt lymphoma: a novel case report of composite lymphoma. Haematologica. 2022; 107: 1999-2003.","DOI":"10.3324\/haematol.2021.280543"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23 Salaverria I, Zettl A, Be\u00e0 S et al.<\/i> Chromosomal alterations detected by comparative genomic hybridization in subgroups of gene expression-defined Burkitt\u2019s lymphoma. Haematologica. 2008; 93: 1327-1334.","DOI":"10.3324\/haematol.13071"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24 Rohde M, Bonn BR, Zimmermann M et al.<\/i> Relevance of ID3-TCF3-CCND3 pathway mutations in pediatric aggressive B-cell lymphoma treated according to the non-Hodgkin Lymphoma Berlin-Frankfurt-M\u00fcnster protocols. Haematologica. 2017; 102: 1091-1098.","DOI":"10.3324\/haematol.2016.156885"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25 Love C, Sun Z, Jima D et al.<\/i> The genetic landscape of mutations in Burkitt lymphoma. Nat Genet. 2012; 44: 1321-1325.","DOI":"10.1038\/ng.2468"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26 Schmitz R, Young RM, Ceribelli M et al.<\/i> Burkitt lymphoma pathogenesis and therapeutic targets from structural and functional genomics. Nature. 2012; 490: 116-120.","DOI":"10.1038\/nature11378"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27 Wagener R, Seufert J, Raimondi F et al.<\/i> The mutational landscape of Burkitt-like lymphoma with 11q aberration is distinct from that of Burkitt lymphoma. Blood. 2019; 133: 962-966.","DOI":"10.1182\/blood-2018-07-864025"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28 Poirel HA, Cairo MS, Heerema NA et al.<\/i> Specific cytogenetic abnormalities are associated with a significantly inferior outcome in children and adolescents with mature B-cell non-Hodgkin\u2019s lymphoma: results of the FAB\/LMB 96 international study. Leukemia. 2009; 23: 323-331.","DOI":"10.1038\/leu.2008.312"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29 Westwood AC, Ali H. Burkitt-like lymphoma with 11q aberration. Diagn Histopathol. 2020; 26: 440-443.","DOI":"10.1016\/j.mpdhp.2020.06.005"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30 Aypar U, Ewalt MD. A very Burkitt-like case of Burkitt-like lymphoma with 11q aberration. Blood. 2022; 139: 1771.","DOI":"10.1182\/blood.2021015098"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31 Asadbeigi SN, Deel CD. Burkitt-like lymphoma with 11q aberration: a case report and review of a rare entity. Case Rep Hematol. 2020; 2020: 8896322.","DOI":"10.1155\/2020\/8896322"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32 Rimsza L, Pittaluga S, Dirnhofer S et al.<\/i> The clinicopathologic spectrum of mature aggressive B cell lymphomas. Virchows Arch. 2017; 471: 453-466.","DOI":"10.1007\/s00428-017-2199-7"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33 Zhang L, Brown LE, Bowen LM et al.<\/i> Application of 2016 WHO classification in the diagnosis of paediatric high-grade MYC -negative mature B-cell lymphoma with Burkitt-like morphological features. J Clin Pathol. 2020; 73: 563-570.","DOI":"10.1136\/jclinpath-2019-206267"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34 Collins K, Mnayer L, Shen P. Burkitt\u2010like lymphoma with 11q aberration. Clin Case Rep. 2019; 7: 1823-1824.","DOI":"10.1002\/ccr3.2361"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35 Moshref Razavi H, Hrynchak M. Unusual presentation of Burkitt-like lymphoma with 11q aberration in an elderly patient. Blood. 2019; 133: 381.","DOI":"10.1182\/blood-2018-08-864728"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36 Okwan-Duodu D, Huang Q. Primary splenic Burkitt-like lymphoma with 11q aberration. Blood. 2021; 138: 1642.","DOI":"10.1182\/blood.2021012824"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37 Rymkiewicz G, Grygalewicz B, Chechlinska M et al.<\/i> A comprehensive flow-cytometry-based immunophenotypic characterization of Burkitt-like lymphoma with 11q aberration. Mod Pathol. 2018; 31: 732-743.","DOI":"10.1038\/modpathol.2017.186"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38 Grygalewicz B, Woroniecka R, Rymkiewicz G et al.<\/i> Genetic progression of post-transplant Burkitt-like lymphoma case with 11q-Gain\/Loss and MYC amplification. Cancer Genet. 2020; 245: 1-5.","DOI":"10.1016\/j.cancergen.2020.05.001"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39 Wang J, Ma L, Guo J, Xi Y, Xu E. Burkitt-like lymphoma with 11q aberration in a patient with AIDS and a patient without AIDS: two cases reports and literature review. Open Med (Wars). 2021; 16: 428-434.","DOI":"10.1515\/med-2021-0246"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40 Azad F, Miranda CJ, Zhang J, Gravina M. Early orbital involvement in a rare diagnosis of Burkitt-like lymphoma with 11q aberration. Proc Bayl Univ Med Cent. 2023; 36: 240-242.","DOI":"10.1080\/08998280.2023.2164916"}],"container-title":["Journal of Clinical and Experimental Hematopathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jslrt\/63\/2\/63_23007\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T05:11:20Z","timestamp":1688188280000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jslrt\/63\/2\/63_23007\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023]]},"references-count":40,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.3960\/jslrt.23007","relation":{},"ISSN":["1346-4280","1880-9952"],"issn-type":[{"value":"1346-4280","type":"print"},{"value":"1880-9952","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023]]},"article-number":"23007"}}